Print page |
Email page
| 
Download PDF
|
Add to briefcase
« Previous Release | Next Release »
PETALUMA, Calif., Aug 03, 2007 (BUSINESS WIRE) --
Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) today announced that financial results for the 2008 fiscal first quarter ended June 30, 2007, will be released before the U.S. market open on August 9, 2007.
The earnings release will be followed by a conference call at 8:00 a.m. PDT (11:00 a.m. EDT) on August 9, 2007, to discuss 2008 fiscal first quarter corporate highlights and financial results.
A live audiocast over the Internet will be available at http://ir.oculusis.com/events.cfm and will be archived for 30 days.
To listen over the phone, please call 1-877-407-4018 (domestic/toll-free) or 1-201-689-8471 (international). A telephone replay will be available for 48 hours after the call at 1-877-660-6853 (domestic/toll-free), or 1-201-612-7415 (international). Please enter account number 3055 and conference identification number 249981.
About Oculus
Oculus Innovative Sciences is a biopharmaceutical company that develops, manufactures and markets a family of Microcyn® Technology-based products intended to help prevent and treat infections in chronic and acute wounds. Oculus' platform technology, called Microcyn, is a non-irritating proprietary oxychlorine formulation designed to treat a wide range of pathogens, including antibiotic-resistant strains of bacteria, viruses, fungi and spores.
Oculus' principal operations are in Petaluma, California, and it conducts operations in Europe and Latin America through its wholly-owned subsidiaries, Oculus Innovative Sciences Netherlands B.V. and Oculus Technologies of Mexico, S.A. de C.V. and Oculus Japan K.K. Oculus' website is www.oculusis.com.
SOURCE: Oculus Innovative Sciences, Inc.
Oculus Innovative Sciences, Inc. Dan McFadden, 425-753-2105 Director of Public and Investor Relations dmcfadden@oculusis.com or The Ruth Group Sara Ephraim (investors), 646-536-7002 sephraim@theruthgroup.com or Jason Rando / Janine McCargo (media), 646-536-7025 / 7033 jrando@theruthgroup.com jmccargo@theruthgroup.com
Copyright Business Wire 2007
News Provided by COMTEX